ライフサイエンスコーパス: chelating agent

1 n phosphatases (fluoride, cantharidin, metal-chelating agents).

2 0-d period when DOTA was used as the yttrium chelating agent.

3 bition by methyl-beta-cyclodextrin, a sterol-chelating agent.

4 by the intraventricular injection of a zinc chelating agent.

5 e- pentamine penta-hydrochloride (TEPA) as a chelating agent.

6 with deferoxamine, a clinically useful iron-chelating agent.

7 s were inhibited in vitro by EGTA, a calcium chelating agent.

8 s of analysis were illustrated using a metal chelating agent.

9 hen choosing the appropriate dose of an iron-chelating agent.

10 his binding property makes thionein a strong chelating agent.

11 t was augmented by desferroioxamine, an iron chelating agent.

12 ges can be substantially blocked by a Ca(2+) chelating agent.

13 irions against disruption by a magnesium ion chelating agent.

14 e, a target interaction element, and a metal chelating agent.

15 L2 agents prepared with open-chain DTPA-type chelating agents.

16 was dramatically reduced in the presence of chelating agents.

17 nd could be inhibited by ubiquitin and metal-chelating agents.

18 activity and was severely inhibited by metal chelating agents.

19 f iron acquisition from low molecular weight chelating agents.

20 n at 6 hours, which was reversible with Ca2+-chelating agents.

21 annexin II was dissociated from virions with chelating agents.

22 s are more immunogenic than other radiometal chelating agents.

23 rom glycation by the use of antioxidants and chelating agents.

24 cessible overview of the field of radiometal chelating agents.

25 was also conducted in the presence of metal chelating agents.

26 e to phytoplankton in the presence of strong chelating agents.

27 HOPO) moieties have been developed as uranyl chelating agents.

28 g activity but were hypersensitive to copper-chelating agents.

29 crystal materials, we no longer require Na+ chelating agents.

30 eptide hydrolysis was inhibited by the metal-chelating agent 1,10-phenanthroline and by the aminopept

31 The macrocyclic chelating agent 1,4,7, 10-tetraazacyclododecane-N,N',N",

32 The macrocyclic chelating agent 1,4,7,10-tetraazacyclododecane-N,N',N",N

33 apten conjugate bearing the macrocyclic ring chelating agent 1,4,7,10-tetraazacyclododecane-N,N',N",N

34 The macrocyclic chelating agent 1,4,7,11-tetraazacyclotetradecane-N,N',N

35 peptides were conjugated to the macrocyclic chelating agent 1,4,8, 11-tetraazacyclotetradecane-N,N',

36 Adx factor binding is inhibited by the zinc-chelating agent, 1,10-o-phenanthroline, suggesting it mi

37 Mechanisms by which the dithiol chelating agent 2, 3-dimercaptopropane-1-sulfonate (DMPS

38 gramme that included treatment with the oral chelating agent 2,3-dimercaptosuccinic acid (DMSA, succi

39 t treatment of lead-exposed animals with the chelating agent 2,3-dimercaptosuccinic acid completely r

40 (epratuzumab), was conjugated to 3 different chelating agents, 2 of which were derivatives of diethyl

41 nerated by complexing aluminum ions with the chelating agent 8-hydroxyquinoline-5-sulfonic acid (HQS)

42 Macrocyclic chelating agents allow formation of stable metallic radi

43 e presence and absence of either reducing or chelating agents allows the analytical speciation of suc

44 he apoform of MT, thionein, is an endogenous chelating agent and activates zinc-inhibited respiration

45 ation both as a potential orally active iron-chelating agent and as a parenteral iron chelator.

46 n (MMC) scaffold which combined a radiometal chelating agent and fluorescent dye into a single moiety

47 at trace level using 8-hydroxyquinoline as a chelating agent and lanthanum(III) as a carrier element

48 optimization with regard to the radionuclide-chelating agent and the linker moiety between chelator a

49 ccelerated by nutrient amendment, the use of chelating agents and novel methods for phosphate amendme

50 be metal ion-dependent and was inhibited by chelating agents and thus was tentatively proposed to be

51 There are several chelating agents and zinc salts for medical therapy.

52 antibody (mAb) when prepared with different chelating agents and, from these data, to estimate the d

53 (DOC), -SH (in cysteine, a well-known Ag(+) chelating agent), and -COO (in trolox, a well-known anti

54 By employing a polyhistidine molecule as a chelating agent, and based on the different signatures o

55 nilinonaphthalenesulfonate, a range of metal-chelating agents, and Hg(2)(+), Cd(2)(+), and Pb(2)(+) i

56 (pH 7-8), its relative resistance to calcium chelating agents, and its ability to cleave after lysine

57 activity was lost after incubation with iron-chelating agents, and no AcnD activity was observed afte

58 bodies through peptides, protein fusions and chelating agents are in preclinical and clinical evaluat

59 Strong chelating agents are less damaging alone than when prese

60 Since strongly bound chelating agents are not always the most effective, achi

61 Strong chelating agents are reported to enhance Cu translocatio

62 2 mM), providing further evidence that these chelating agents are substrates for Oat1.

63 plexes formed between MeHg and these anionic chelating agents are transported from blood into proxima

64 solution and prevented by including the Ca2+ chelating agent BAPTA (10 mM) in the recording electrode

65 on was reduced by the membrane-permeant Ca2+-chelating agent BAPTA-AM.

66 n the perspective of developing bifunctional chelating agents (BCAs), this new synthetic strategy off

67 ion of perfluoro aryl azides by bifunctional chelating agents (BFCAs) capable of forming high specifi

68 BFCAs yields novel bifunctional photolabile chelating agents (BFPCAs) that are useful for covalent a

69 e surfactant molecules form micelles and the chelating agent bridges the MOF and the micelles, making

70 l parameters (nonionic and ionic surfactant, chelating agent, bromate, bromide, and pH) led to optima

71 ctivity that was not affected by reducing or chelating agents but was inhibited by specific synthetic

72 e prevented with calpain inhibitors, calcium-chelating agents, calpain knockdown, or calpastatin over

73 Chelating agents can control the speciation and reactivi

74 ical "braking" system was achieved by adding chelating agents capable of sequestering the metal ion e

75 ntrast to this behavior, addition of an iron chelating agent (citrate) to the protein solution result

76 ctant (cetyltrimethylammonium bromide) and a chelating agent (citric acid), for the generation of a m

77 tions then occur in which the enzyme and the chelating agent compete for free Mg2+ ions.

78 more effective than that by the known metal chelating agents CQ, EDTA, and phen.

79 n metal ion-chelating agent stereochemistry, chelating agent denticity, and number of bridging ligand

80 ll protection, comparable to synthetic metal chelating agents desferrioxamine and clioquinol.

81 The chelating agent did not alter the binding affinity to it

82 EDTA, a powerful chelating agent, did not have any significant effect on

83 Treating infant formulas with the chelating agent diethylene triamine pentaacetic acid (DT

84 eled with 185 MBq [5 mCi] of (111)In via the chelating agent DOTA).

85 Addition of the chelating agent EDTA abolished the in vitro Nkd-Dsh inte

86 The synthetic chelating agent EDTA can mobilize radionuclides and heav

87 Experiments using the chelating agent EDTA to disrupt integrin function result

88 m ions (using a DM-Nitrophen complex), and a chelating agent (EDTA).

89 Chelating agents (EDTA formulations) reduced E. coli CFU

90 Inclusion of divalent chelating agents (EDTA) with fraction nu, an otherwise a

91 -A, which was reduced by the divalent cation-chelating agent, EDTA.

92 The calcium chelating agent EGTA also inhibits the IL-10 production

93 The calcium chelating agent EGTA inhibited ACTH-induced SAPK activit

94 Chelating agents EGTA and EDTA also inhibited nuclease a

95 transient was attenuated by the addition of chelating agents EGTA or BAPTA, cation channel pore bloc

96 required to achieve the same efficacy as the chelating agent ethylenediamine tetraacetic acid.

97 The chelating agent ethylenediaminetetraacetate (EDTA) selec

98 Phytosiderophores (PS) are natural chelating agents, exuded by graminaceous plants (grasses

99 n from metallothionein using the fluorescent chelating agents FluoZin-3 and RhodZin-3 reveal at least

100 poration of hydroxamic acid as the bidentate chelating agent for catalytic Zn(2+), placement of a sul

101 A NOTA ligand is the chelating agent for the (68)Ga, and two related opioid p

102 ral DMSA was a pharmacodynamically effective chelating agent for the treatment of severe childhood le

103 was also observed; in the presence of excess chelating agent, free metals were removed and the iron-s

104 The recent discovery that certain chelating agents greatly facilitate metal uptake by soil

105 Also treatment with copper chelating agents has less hepatic treatment failures whe

106 and Co(III) complexes with the multidentate chelating agents iminodiacetic acid, nitrilotriacetic ac

107 been developed using the incorporation of a chelating agent in a common organic solvent, dimethyl su

108 Nitrilotriacetate (NTA) is an important chelating agent in detergents and has also been used ext

109 or precursor cadmium complex that works as a chelating agent in order to increase optical and electri

110 suggests the importance of the alkali metal chelating agent in the reversibility of dinitrogen bindi

111 etal cations from nucleic acid substrates to chelating agents in the gas phase.

112 (IV) with Gallocyanin (GC(+)) and glycine as chelating agents in the mixed surfactant media, Polyethy

113 Treatment of DHHC3 with chelating agents in vitro replicated both the specific s

114 pH 8-9 and a molar excess of a bifunctional chelating agent is added.

115 ster, whereas the reverse is observed when a chelating agent is the zinc acceptor.

116 EDTA, a common chelating agent, is becoming a major organic pollutant i

117 were labeled with 111In using a bifunctional chelating agent, LiLo.

118 d by treatment of cells with the cholesterol chelating agent, methyl-beta-cyclodextrin, that is thoug

119 n important translational conclusion is that chelating agents might help delay nuclear sclerosis.

120 ell as the concentration of other biological chelating agents might well determine the direction of z

121 The chelating agent, N-[2-amino-3-(p-isothiocyanatophen-yl)p

122 Using the chelating agent nitrilotriacetic acid, we have establish

123 application of UV-Fenton processes with two chelating agents, nitrilotriacetic acid (NTA) and [S,S]-

124 of iron (Fe) from the growth medium with the chelating agent o-phenanthroline (20 microM) mimics aero

125 arious signaling molecules, transporters and chelating agents of HM metabolism is poorly understood.

126 letely prevented by the addition of either a chelating agent or lens proteins.

127 In the absence of chelating agents or nonsynergistic anions, the diferric

128 The removal of Ca(2+) with chelating agents partially releases the bound PC1.

129 this system being less influenced by pH and chelating agents present in the extracts.

130 Well-known as specific iron chelating agents produced by bacteria, it is shown that

131 Indeed, removal of calcium ions by chelating agents promotes cleavage of the BT-R1 ectodoma

132 ubstantially surpassing conventional Gd(III) chelating agents (r1 approximately 3 mM(-1)s(-1) at 4.7

133 Loss of (225)Ac from acyclic chelating agents resulted in high liver uptake and poor

134 ily removed by treatment of Zn2Fur with zinc chelating agents, resulting in Zn1Fur with ca. 0.9 mol o

135 Removal of iron with chelating agents results in dissociation of the complex;

136 uman growth hormone, rhGH) modified with the chelating agent S-2-(4-isothiocyanatobenzyl)-1,4,7-triaz

137 ctive of this work was to evaluate the novel chelating agent SarAr (1-N-(4-aminobenzyl)-3, 6,10,13,16

138 a the secretion of low-molecular-weight iron-chelating agents (siderophores).

139 ma mandarin fruits was extracted to obtain a chelating agent-soluble pectin fraction (ChSS), a dilute

140 and Co(III), subtle differences in metal ion-chelating agent stereochemistry, chelating agent dentici

141 However, they do react in the presence of a chelating agent such as EDTA.

142 holoprotein reacts only in the presence of a chelating agent such as ethylenediaminetetraacetate (EDT

143 to self-associate, and calmodulin or Ca(2+)-chelating agents such as ethylene glycol bis(beta-aminoe

144 These results demonstrate that iron-chelating agents such as PCIH may be of benefit in the t

145 nein, on the other hand, is mediated by zinc-chelating agents such as Tris buffer, citrate, or glutat

146 mutations stabilize only in the presence of chelating agents, such as EDTA.

147 Chelating agents, such as physiological ligands with mod

148 Thus, T is an effective, endogenous chelating agent, suggesting the existence of a hitherto

149 f interest is first conjugated to a suitable chelating agent that forms stable complexes with the ele

150 The peptide is first conjugated to a chelating agent that is able to form stable complexes wi

151 While certain soil microbes produce chelating agents that enhance the solubility of iron, th

152 reaction based on the use of cation-specific chelating agents that yields 1,3-dienes with predictable

153 lly important molecules through a variety of chelating agents, the choice of which depends upon the i

154 xide and free-radical formation, use of iron chelating agents, the potential role of hypoxia-inducibl

155 events produced by the translocation of the chelating agent through an alpha-hemolysin pore in the a

156 The ratio of the concentration of the chelating agent to that of the magnesium ions was used t

157 e-labeled compounds by attaching known Tc/Re chelating agents to an amino-functionalized PSMA inhibit

158 Adding chelating agents to soil to increase the bioavailability

159 Furthermore, the amount of the chelating agent used also affects the phase purity and e

160 Currently, chelating agents used in (68)Ga radiopharmaceuticals do

161 to the disease itself, iron overload or the chelating agents used.

162 stability increased to a great extent when a chelating agent was added.

163 However, when the surfactant or the chelating agent was applied individually, no mesoMOF was

164 ,N" '-tetraacetic acid (DOTA), a macrocyclic chelating agent well recognized as forming very stable c

165 Rather than using the chelating agents which are commonly used in CPE to form

166 )3](+) core (L8-L10), traditional NxSy-based chelating agents with varying charge and polarity for th

167 : a pore blocking method and a micromolecule-chelating agent within the core.